These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12943827)

  • 1. Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis.
    Bhimani EK; Serracino-Inglott F; Sarela AI; Batten JJ; Mathie RT
    J Surg Res; 2003 Jul; 113(1):172-8. PubMed ID: 12943827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
    Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
    World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
    Van de Casteele M; Omasta A; Janssens S; Roskams T; Desmet V; Nevens F; Fevery J
    Gut; 2002 Sep; 51(3):440-5. PubMed ID: 12171971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide.
    Chu CJ; Lee FY; Wang SS; Lu RH; Tsai YT; Lin HC; Hou MC; Chan CC; Lee SD
    Clin Sci (Lond); 1997 Sep; 93(3):219-25. PubMed ID: 9337636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC
    J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.
    Sarela AI; Mihaimeed FM; Batten JJ; Davidson BR; Mathie RT
    Gut; 1999 May; 44(5):749-53. PubMed ID: 10205218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
    Albornoz L; Bandi JC; de las Heras M; Mastai R
    Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
    Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
    J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats.
    Weigert AL; Martin PY; Niederberger M; Higa EM; McMurtry IF; Gines P; Schrier RW
    Hepatology; 1995 Dec; 22(6):1856-62. PubMed ID: 7489998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
    Rockey DC; Chung JJ
    Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis.
    Sánchez-Rodríguez A; Criado M; Rodríguez-López AM; Esteller A; Martín de Arriba A; López-Novoa JM
    Clin Sci (Lond); 1998 Jun; 94(6):637-43. PubMed ID: 9854462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis.
    Xu L; Carter EP; Ohara M; Martin PY; Rogachev B; Morris K; Cadnapaphornchai M; Knotek M; Schrier RW
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1110-5. PubMed ID: 11097630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.